NCT07063641

Brief Summary

Subacromial pain syndrome (SPS) is one of the most common causes of shoulder pain, leading to significant disability and socioeconomic burden. Although percutaneous electrical nerve stimulation (PENS) targeting the suprascapular nerve (SN) has shown positive therapeutic outcomes, individual response to the intervention varies considerably. This study aims to develop a multivariable predictive model to estimate clinical response to SN-targeted PENS in patients with SPS. The model will be built using clinical, psychological, and neural mechanosensitivity variables. The goal is to enhance patient selection and guide personalized treatment strategies.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
269

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Sep 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Sep 2025Nov 2026

First Submitted

Initial submission to the registry

July 3, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 14, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

September 20, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2026

Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

1.1 years

First QC Date

July 3, 2025

Last Update Submit

July 3, 2025

Conditions

Keywords

Percutaneous Electrical Nerve StimulationSuprascapular NerveNeural MechanosensitivityMusculoskeletal PainUltrasound-Guided InterventionsSubacromial pain syndrome

Outcome Measures

Primary Outcomes (1)

  • Pain intensity

    Pain intensity will be measured with a 100 mm Visual Analogue Scale (VAS), ranging from 0 mm (no pain) to 100 mm (worst imaginable pain). This is the primary outcome used to evaluate the clinical response to a single ultrasound-guided session of percutaneous electrical nerve stimulation (PENS) targeting the suprascapular nerve in patients with subacromial pain syndrome. This outcome will be used as the dependent variable in the multivariable predictive model.

    4 weeks post-intervention

Study Arms (1)

Suprascapular Nerve PENS

EXPERIMENTAL

Participants in this arm will receive a single ultrasound-guided session of percutaneous electrical nerve stimulation (PENS) targeting the suprascapular nerve. The procedure involves needle placement adjacent to the suprascapular nerve and electrical stimulation for 30 minutes.

Device: Percutaneous Electrical Nerve Stimulation (PENS)

Interventions

Ultrasound-guided percutaneous electrical nerve stimulation applied to the suprascapular nerve using a monophasic or biphasic current at 10 Hz frequency and 250 μs pulse width. Intensity is progressively increased to patient tolerance, aiming to induce visible muscle contractions of the supraspinatus and infraspinatus. Duration of the session is 30 minutes.

Suprascapular Nerve PENS

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged between 18 and 65 years.
  • Clinical diagnosis of subacromial pain syndrome (SAPS), based on the following clinical criteria:
  • Pain localized to the anterolateral shoulder region.
  • Symptoms present for more than 6 weeks.
  • Painful arc during shoulder abduction.
  • Positive Neer or Hawkins-Kennedy impingement signs.
  • Positive Jobe (empty can) test or external rotation resistance test.
  • Visual Analogue Scale (VAS) for shoulder pain ≥ 3/10 in the previous week.
  • Able to understand study procedures and sign informed consent.

You may not qualify if:

  • Bilateral shoulder pain.
  • History of fracture, dislocation, or surgical intervention on the affected shoulder.
  • Presence of other shoulder pathologies such as adhesive capsulitis (frozen shoulder), glenohumeral instability, or full-thickness rotator cuff tear.
  • Medical contraindications for PENS application (e.g., active anticoagulation, pregnancy, or decompensated psychiatric condition).
  • Diagnosed cervical radiculopathy or myelopathy.
  • Neurological or cognitive disorders interfering with study participation.
  • Presence of chronic widespread pain syndromes, such as fibromyalgia.
  • Belonephobia (severe needle phobia) that prevents intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Musculoskeletal Pain

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Uncontrolled, single-arm clinical trial aimed at developing a multivariable predictive model of response to suprascapular nerve-targeted PENS in patients with subacromial pain syndrome.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator, Department of Physiotherapy, University of Alcalá and Centro Superior Universitario La Salle

Study Record Dates

First Submitted

July 3, 2025

First Posted

July 14, 2025

Study Start

September 20, 2025

Primary Completion (Estimated)

November 10, 2026

Study Completion (Estimated)

November 10, 2026

Last Updated

July 14, 2025

Record last verified: 2025-07